middle-aged man holding fist over his mouth as he coughs

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trial

Ages

Over 60 years old

Location

Columbus, OH

Compensation

For qualified participants
middle-aged man holding fist over his mouth as he coughs

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trials in Columbus

Aventiv Research is currently participating in a respiratory syncytial virus (RSV) vaccine study at our Columbus, Ohio location. RSV affects the lungs and its bronchioles. Severe infection with RSV can lead to pneumonia and bronchiolitis and may require hospital care. People at greatest risk of severe infection are the very young (those less than six months old), those over the age of 65 and those of any age who have heart or lung conditions or a weakened immune system. RSV can also make existing heart and lung problems worse. Like any other drug, a new vaccine must be tested on human subjects before being approved for use by the Federal Drug Administration (FDA).

Enroll Now

Respiratory Syncytial Virus (RSV) Vaccine Clinical Trial

The primary objective of this clinical trial is to evaluate the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine in healthy older adults. You may qualify for this study if you are at least years of age and are:

  • A healthy volunteer who is overtly healthy as determined by medical evaluation

AND

  • Have not received any other licensed or investigational RSV vaccine preceding the trial vaccination

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.

Ready to Volunteer?

Volunteer today to see if you qualify for our respiratory syncytial virus (RSV) vaccine clinical research study. Qualified volunteers may be compensated for time and travel.